TrialThe Lancet. Infectious diseases2017

Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial.

Luis Rivera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.